Solid Biosciences Inc. (SLDB) NASDAQ
6.58
-0.61(-8.48%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
6.58
-0.61(-8.48%)
Currency In USD
| Market Cap | 493.53M |
| Enterprise Value | 454.79M |
| P/E Ratio | -3.77 |
| PEG Ratio | -0.1 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 1.93 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -1.24 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.45 |
| Return On Equity | -0.74 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -1.64M |
| EBITDA | -177.57M |
| Net Income | -174.33M |
| Diluted EPS | -1.99 |
| Total Cash | 381.32M |
| Total Cash/Share | 3.47 |
| Total Debt | 20.67M |
| Total Debt/Equity | 0.06 |
| Current Ratio | 13.1 |
| Book Value Per Share | 3.41 |
| 52-Week Change | 85.88 |
| 52-Week High | 8.87 |
| 52-Week Low | 3.41 |
| Moving Average 50 Days | 7.42 |
| Moving Average 200 Days | 6.2 |
| Average Volume | 1.31M |
| Shares Outstanding | 77.91M |
| % Held by Institutions | 105.24 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:15 |
| Last Split Date | October 28, 2022 |